These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7937347)

  • 1. Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8S.
    Gerhardt P; Voits M; Fink H; Huston JP
    Peptides; 1994; 15(4):689-97. PubMed ID: 7937347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s.
    Huston JP; Schildein S; Gerhardt P; Privou C; Fink H; Hasenöhrl RU
    Peptides; 1998; 19(1):27-37. PubMed ID: 9437734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential startle reactivity following central CCK-8S and systemic Boc CCK-4 administration in mice: antecedent stressor history and testing condition.
    Hebb AL; Zacharko RM; Bowie JP; Drolet G
    Behav Neurosci; 2003 Aug; 117(4):704-15. PubMed ID: 12931956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholecystokinin tetrapeptide and sulfated cholecystokinin octapeptide in rat models of anxiety.
    Rex A; Barth T; Voigt JP; Domeney AM; Fink H
    Neurosci Lett; 1994 May; 172(1-2):139-42. PubMed ID: 8084519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze.
    Zanoveli JM; Netto CF; Guimarães FS; Zangrossi H
    Peptides; 2004 Nov; 25(11):1935-41. PubMed ID: 15501525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Kariya K; Tanaka J; Nomura M
    Brain Res; 1994 Sep; 657(1-2):1-6. PubMed ID: 7820607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats.
    Blandizzi C; Natale G; Carignani D; Colucci R; Lazzeri G; Del Tacca M
    Neurosci Lett; 1995 Jun; 193(1):13-6. PubMed ID: 7566655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraperitoneal, but not subcutaneous, administration of the sulphated cholecystokinin octapeptide (CCK-8S) inhibits operant and nonoperant food intake in rats: implications for the CCK-satiety hypothesis.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):167-71. PubMed ID: 10389118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of the cyclic cholecystokinin peptide analogue JMV-320.
    Hadjiivanova C; Kehayov R; Petkov VV; Amblard M; Martinez J
    Peptides; 1995; 16(5):815-9. PubMed ID: 7479320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 'nose-poke habituation' validation with post-trial diazepam- and cholecystokinin-induced hypo- and hypermnesia.
    Voits M; Fink H; Gerhardt P; Huston JP
    J Neurosci Methods; 1995 Mar; 57(1):101-5. PubMed ID: 7791360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Britton DR; Yahiro L; Cullen MJ; Kerwin JF; Kopecka H; Nadzan AM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):779-83. PubMed ID: 2623030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-8S increases dynorphin B, aspartate and glutamate release in the fronto-parietal cortex of the rat via different receptor subtypes.
    You ZB; Godukhin O; Goiny M; Nylander I; Ungerstedt U; Terenius L; Hökfelt T; Herrera-Marschitz M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May; 355(5):576-81. PubMed ID: 9151295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of two cholecystokinin analogues: JMV 236 and JMV 179.
    Hadjiivanova C; Petkov VV; Kehayov R; Martinez J
    Neuropeptides; 1994 Sep; 27(3):163-7. PubMed ID: 7816187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central D-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice.
    Hebb AL; Zacharko RM
    Brain Res; 2003 Apr; 970(1-2):9-19. PubMed ID: 12706244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain.
    Lodge DJ; Short JL; Mercer LD; Beart PM; Lawrence AJ
    Peptides; 2000 Mar; 21(3):379-86. PubMed ID: 10793220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons.
    Oz M; Yang KH; Shippenberg TS; Renaud LP; O'Donovan MJ
    J Neurophysiol; 2007 Sep; 98(3):1108-14. PubMed ID: 17581850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholecystokinin blockade of emotional stress- and CRF-induced colonic motor alterations in rats: role of the amygdala.
    Gué M; Tekamp A; Tabis N; Junien JL; Buéno L
    Brain Res; 1994 Sep; 658(1-2):232-8. PubMed ID: 7834346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of cholecystokinin sulphated octapeptide (CCK-8S) induces changes on rat amino acid tissue levels and on a behavioral test for anxiety.
    Acosta GB
    Gen Pharmacol; 1998 Oct; 31(4):637-41. PubMed ID: 9792229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release.
    Pérez de la Mora M; Hernández-Gómez AM; Arizmendi-García Y; Jacobsen KX; Lara-García D; Flores-Gracia C; Crespo-Ramírez M; Gallegos-Cari A; Nuche-Bricaire A; Fuxe K
    Eur J Neurosci; 2007 Dec; 26(12):3614-30. PubMed ID: 18088282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.